Serum Institute of India launches Rabishield, developed in partnership with UMMS
The Serum Institute of India announced the global launch of a rabies monoclonal antibody developed in partnership with UMass Medical School. Rabishield, a U.S.-patented product, will help close the gaps in rabies prevention and is expected to reduce the rabies mortality rate in India.
UMass Medical School announces The Li Weibo (李伟波) Institute for Rare Diseases Research
A new institute for rare diseases research at UMass Medical School will build on the school’s already substantial accomplishments in the fields of gene therapy, RNA biology and RNAi technology to accelerate the development of novel therapeutics for a host of disorders.
Convocation 2017: Chancellor recognizes ‘smart minds, great science and genuine collegiality’ at UMMS
In his Convocation address, Chancellor Michael F. Collins praised the campus community for its collaborative environment and awarded Chancellor’s Medals to four distinguished faculty for their exemplary teaching, scholarship, clinical excellence and service.
U.S. Rep. Jim McGovern, Worcester leaders support critical NIH funding for UMass Medical School
President Donald Trump’s proposal to cut 22 percent from the FY18 National Institutes of Health budget would cost UMass Medical School from $45 million to $74 million a year, Chancellor Michael F. Collins said at an Aug. 16 panel discussion on NIH funding at UMMS.
Michael Green and Allan Jacobson elected to American Academy of Arts and Sciences
Two distinguished scientists from UMass Medical School—Michael Green, MD, PhD, and Allan Jacobson, PhD—have been elected to the American Academy of Arts and Sciences Class of 2018. They join a group of 213 individuals elected this year that includes Barack Obama and 2018 UMMS Commencement speaker Huda Y. Zoghbi, MD.